Related Experiment Video
Updated: Aug 6, 2026
09:06
Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture
Published on: December 22, 2016
Sleep disturbances reported by refractory partial-onset epilepsy patients receiving polytherapy
Xiao Xu1, Nancy A Brandenburg, Anne M McDermott
1Covance Market Access Services, Gaithersburg, Maryland 20878, USA. xiao.xu@covance.com
Epilepsia
|August 5, 2006
Summary
Sleep disturbances are common in epilepsy patients and negatively impact their quality of life. Addressing these overlooked issues is crucial for improving well-being in epilepsy care.
Area of Science:
- Neurology
- Sleep Medicine
- Quality of Life Research
Background:
- Sleep disturbances are prevalent in epilepsy but often understudied.
- Few investigations have explored the impact of sleep issues on epilepsy patients' lives.
Purpose of the Study:
- To investigate the prevalence and impact of sleep disturbances in adult patients with partial-onset epilepsy.
- To assess the association between sleep problems and health-related quality of life (HRQoL).
Main Methods:
- A cross-sectional survey of 201 adult partial-onset epilepsy patients on stable antiepileptic drug regimens.
- Patients completed the Medical Outcomes Study (MOS) Sleep Scale, Quality of Life in Epilepsy-10 (QOLIE-10), and EuroQol-5D (EQ-5D).
- Correlations and analysis of variance were used to evaluate associations between sleep, HRQoL, and clinical/demographic factors.
Main Results:
- 34% of patients had diagnosed sleep disturbances; 10% used sleep medications.
- Sleep disturbances were linked to significantly poorer QOLIE-10 and EQ-5D scores.
- Higher sleep problem scores correlated with worse HRQoL and were associated with recent seizures, anxiety, and depression.
Conclusions:
- Sleep disturbances in partial-onset epilepsy are frequently overlooked but significantly impair functioning and well-being.
- These sleep issues contribute substantially to the overall burden of epilepsy.
- Clinical attention to sleep disturbances is vital for improving patient outcomes.
Related Concept Videos
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications